Xenetic Biosciences (XBIO) Misses Q1 EPS by 13c

Xenetic Biosciences (NASDAQ: XBIO) reported Q1 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits